Frederick M Dirbas
Overview
Explore the profile of Frederick M Dirbas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
3479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh P, Agnese D, Amin M, Barrio A, van den Bruele A, Burke E, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):899-911.
PMID: 39538100
Bilateral risk-reducing mastectomy (BRRM) is the surgical removal of both breasts to reduce the risk of cancer. In this Society of Surgical Oncology position statement, we review the literature addressing...
2.
Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer
Park K, Showalter S, Dirbas F
Ann Surg Oncol
. 2024 Jul;
31(9):5483-5486.
PMID: 39003374
This is an executive summary of the most recent American Society for Radiation Oncology (ASTRO) guidelines on use of partial breast irradiation in early-stage breast cancer.In the conscientious pursuit of...
3.
Singh P, Agnese D, Amin M, Barrio A, van den Bruele A, Burke E, et al.
Ann Surg Oncol
. 2024 Jan;
31(4):2212-2223.
PMID: 38261126
Rates of contralateral mastectomy (CM) among patients with unilateral breast cancer have been increasing in the United States. In this Society of Surgical Oncology position statement, we review the literature...
4.
Confino H, Sela Y, Epshtein Y, Malka L, Goldshtein M, Chaisson S, et al.
Cells
. 2023 Oct;
12(20).
PMID: 37887283
Background: Immune checkpoint inhibitors have transformed clinical oncology. However, their use is limited as response is observed in only ~20-50% of patients. Previously, we demonstrated that treating CT26 tumor-bearing mice...
5.
Confino H, Dirbas F, Goldshtein M, Yarkoni S, Kalaora R, Hatan M, et al.
Cancer Cell Int
. 2022 Dec;
22(1):405.
PMID: 36514083
Background: In-situ tumor ablation provides the immune system with the appropriate antigens to induce anti-tumor immunity. Here, we present an innovative technique for generating anti-tumor immunity by delivering exogenous ultra-high...
6.
Sikandar S, Gulati G, Antony J, Fetter I, Kuo A, Ho W, et al.
Sci Adv
. 2022 Nov;
8(45):eabm3548.
PMID: 36351009
Metastasis is responsible for most breast cancer-related deaths; however, identifying the cellular determinants of metastasis has remained challenging. Here, we identified a minority population of immature / tumor epithelial cells...
7.
Hah J, Lee E, Shrestha R, Pirrotta L, Huddleston J, Goodman S, et al.
Int J Surg
. 2021 Oct;
95:106100.
PMID: 34600123
Background: We aimed to identify preoperative psychosocial factors associated with return-to-work (RTW) and the associated cost of productivity loss due to work absenteeism following surgery. Research demonstrates a high economic...
8.
Hah J, Hilmoe H, Schmidt P, McCue R, Trafton J, Clay D, et al.
J Pain Res
. 2020 Nov;
13:2959-2970.
PMID: 33239904
Background: Preoperative patient-specific risk factors may elucidate the mechanisms leading to the persistence of pain and opioid use after surgery. This study aimed to determine whether similar or discordant preoperative...
9.
Natarajan A, Srinivas S, Azevedo C, Greene L, Bauchet A, Jouannot E, et al.
Mol Imaging
. 2020 Oct;
19:1536012120939398.
PMID: 33104454
An antigen binding fragment (BFab) derived from a tumor-associated mucin 1-sialoglycotope antigen (CA6) targeting antibody (huDS6) was engineered. We synthesized a companion diagnostic positron emission tomography (PET) tracer by radiolabeling...
10.
Gutkin P, Ganjoo K, Lohman M, von Eyben R, Charville G, Nazerali R, et al.
Am J Clin Oncol
. 2020 Sep;
43(11):820-825.
PMID: 32889893
Objective: Angiosarcoma of the breast is rare and has a poor prognosis. We reviewed our institution's experience with this disease to characterize presentation, identify management patterns, and report outcomes. Methods:...